PWMG
MDCO

Prestige Wealth Management Group’s Medicines Co MDCO Stock Holding History

Prestige Wealth Management Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100
Closed -$8K – 1059
2019
Q4 		$8K Hold
100
– – ﹤0.01% 373
2019
Q3 		$5K Hold
100
– – ﹤0.01% 425
2019
Q2 		$4K Hold
100
– – ﹤0.01% 428
2019
Q1 		$3K Hold
100
– – ﹤0.01% 445
2018
Q4 		$2K Buy
+100
New +$2.33K ﹤0.01% 921

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Prestige Wealth Management Group's MDCO Position: Q1 2020 in Review

Prestige Wealth Management Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 100 shares — an estimated $8K sold.

Prestige Wealth Management Group first reported a position in MDCO in Q4 2018 and held it in 5 quarters. The position peaked at $8K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Prestige Wealth Management Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Prestige Wealth Management Group sold 100 Medicines Co shares in Q1 2020, an estimated $8K.
  • Prestige Wealth Management Group first reported a position in Medicines Co in Q4 2018 and held it in 5 quarters.
  • Prestige Wealth Management Group's Medicines Co position peaked at $8K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Prestige Wealth Management Group's 13F filing for Q1 2020, filed 15 May 2020.